Skip to main content
Top
Published in: Journal of Gastrointestinal Surgery 10/2007

01-10-2007

Trends and Disparities in Regionalization of Pancreatic Resection

Authors: Taylor S. Riall, Karl A. Eschbach, Courtney M. Townsend Jr., William H. Nealon, Jean L. Freeman, James S. Goodwin

Published in: Journal of Gastrointestinal Surgery | Issue 10/2007

Login to get access

Abstract

Background

The current recommendation is that pancreatic resections be performed at hospitals doing >10 pancreatic resections annually.

Objective

To evaluate the extent of regionalization of pancreatic resection and the factors predicting resection at high-volume centers (>10 cases/year) in Texas.

Methods

Using the Texas Hospital Inpatient Discharge Public Use Data File, we evaluated trends in the percentage of patients undergoing pancreatic resection at high-volume centers (>10 cases/year) from 1999 to 2004 and determined the factors that independently predicted resection at high-volume centers.

Results

A total of 3,189 pancreatic resections were performed in the state of Texas. The unadjusted in-hospital mortality was higher at low-volume centers (7.4%) compared to high-volume centers (3.0%). Patients resected at high-volume centers increased from 54.5% in 1999 to 63.3% in 2004 (P = 0.0004). This was the result of a decrease in resections performed at centers doing less than five resections/year (35.5% to 26.0%). In a multivariate analysis, patients who were >75 (OR = 0.51), female (OR = 0.86), Hispanic (OR = 0.58), having emergent surgery (OR = 0.39), diagnosed with periampullary cancer (OR = 0.68), and living >75 mi from a high-volume center (OR = 0.93 per 10-mi increase in distance, P < 0.05 for all OR) were less likely to be resected at high-volume centers. The odds of being resected at a high-volume center increased 6% per year.

Conclusions

Whereas regionalization of pancreatic resection at high-volume centers in the state of Texas has improved slightly over time, 37% of patients continue to undergo pancreatic resection at low-volume centers, with more than 25% occurring at centers doing less than five per year. There are obvious demographic disparities in the regionalization of care, but additional unmeasured barriers need to be identified.
Literature
1.
go back to reference Gordon TA, Burleyson GP, Tielsch JM, Cameron JL. The effects of regionalization on cost and outcome for one general high-risk surgical procedure. Ann Surg 1995;221:43–49.PubMedCrossRef Gordon TA, Burleyson GP, Tielsch JM, Cameron JL. The effects of regionalization on cost and outcome for one general high-risk surgical procedure. Ann Surg 1995;221:43–49.PubMedCrossRef
2.
go back to reference Lieberman MD, Kilburn H, Lindsey M, Brennan MF. Relation of perioperative deaths to hospital volume among patients undergoing pancreatic resection for malignancy. Ann Surg 1995;222:638–645.PubMedCrossRef Lieberman MD, Kilburn H, Lindsey M, Brennan MF. Relation of perioperative deaths to hospital volume among patients undergoing pancreatic resection for malignancy. Ann Surg 1995;222:638–645.PubMedCrossRef
3.
go back to reference Ho V, Heslin MJ. Effect of hospital volume and experience on in-hospital mortality for pancreaticoduodenectomy. Ann Surg 2003;237:509–514.PubMedCrossRef Ho V, Heslin MJ. Effect of hospital volume and experience on in-hospital mortality for pancreaticoduodenectomy. Ann Surg 2003;237:509–514.PubMedCrossRef
4.
go back to reference van Heek NT, Kuhlmann KFD, Scholten RJ, et al. Hospital volume and mortality after pancreatic resection. A systematic review and an evaluation of intervention in the Netherlands. Ann Surg 2005;242:781–790.PubMedCrossRef van Heek NT, Kuhlmann KFD, Scholten RJ, et al. Hospital volume and mortality after pancreatic resection. A systematic review and an evaluation of intervention in the Netherlands. Ann Surg 2005;242:781–790.PubMedCrossRef
5.
go back to reference Birkmeyer JD, Sun Y, Goldfaden A, Birkmeyer NJO, Stukel TA. Volume and process of care in high-risk cancer surgery. Cancer 2006;106:2476–2481.PubMedCrossRef Birkmeyer JD, Sun Y, Goldfaden A, Birkmeyer NJO, Stukel TA. Volume and process of care in high-risk cancer surgery. Cancer 2006;106:2476–2481.PubMedCrossRef
6.
go back to reference Kotwall CA, Maxwell JG, Brinker CC, Koch GG, Covington DL. National estimates of mortality rates for radical pancreaticoduodenectomy in 25,000 patients. Ann Surg Oncol 2002;9:847–854.PubMedCrossRef Kotwall CA, Maxwell JG, Brinker CC, Koch GG, Covington DL. National estimates of mortality rates for radical pancreaticoduodenectomy in 25,000 patients. Ann Surg Oncol 2002;9:847–854.PubMedCrossRef
7.
go back to reference Gouma DJ, van Geenen RCI, van Gulik TM, et al. Rates of complications and death after pancreaticoduodenectomy: Risk factors and the impact of hospital volume. Ann Surg 2000;6:786–795.CrossRef Gouma DJ, van Geenen RCI, van Gulik TM, et al. Rates of complications and death after pancreaticoduodenectomy: Risk factors and the impact of hospital volume. Ann Surg 2000;6:786–795.CrossRef
8.
go back to reference Gordon TA, Bowman HM, Bass EB, et al. Complex gastrointestinal surgery: Impact of provider experience on clinical and economic outcomes. J Am Coll Surg 1999;189:46–56.PubMedCrossRef Gordon TA, Bowman HM, Bass EB, et al. Complex gastrointestinal surgery: Impact of provider experience on clinical and economic outcomes. J Am Coll Surg 1999;189:46–56.PubMedCrossRef
9.
go back to reference Gordon TA, Bowman HM, Tielsch JM, Bass EB, Burleyson GP, Cameron JL. Statewide regionalization of pancreaticoduodenectomy and its effect on in-hospital mortality. Ann Surg 1998;228:71–78.PubMedCrossRef Gordon TA, Bowman HM, Tielsch JM, Bass EB, Burleyson GP, Cameron JL. Statewide regionalization of pancreaticoduodenectomy and its effect on in-hospital mortality. Ann Surg 1998;228:71–78.PubMedCrossRef
10.
go back to reference Sosa JA, Bowman HM, Bass EB, et al. Importance of hospital volume in the overall management of pancreatic cancer. Ann Surg 1998;228:429–438.PubMedCrossRef Sosa JA, Bowman HM, Bass EB, et al. Importance of hospital volume in the overall management of pancreatic cancer. Ann Surg 1998;228:429–438.PubMedCrossRef
11.
go back to reference Birkmeyer JD, Warshaw AL, Finlayson SRG, Grove MR, Tosteson ANA. Relationship between hospital volume and late survival after pancreaticoduodenectomy. Surgery 1999;126:178–183.PubMed Birkmeyer JD, Warshaw AL, Finlayson SRG, Grove MR, Tosteson ANA. Relationship between hospital volume and late survival after pancreaticoduodenectomy. Surgery 1999;126:178–183.PubMed
12.
go back to reference Birkmeyer JD, Stukel TA, Siewers AE, Goodney PP, Wennberg DE, Lucas FL. Surgeon volume and operative mortality in the United States. N Engl J Med 2003;349:2117–2127.PubMedCrossRef Birkmeyer JD, Stukel TA, Siewers AE, Goodney PP, Wennberg DE, Lucas FL. Surgeon volume and operative mortality in the United States. N Engl J Med 2003;349:2117–2127.PubMedCrossRef
13.
go back to reference Rosemurgy AS, Bloomston M, Serafini FM, et al. Frequency with which surgeons undertake pancreaticoduodenectomy determines length of stay, hospital charges, and in-hospital mortality. J Gastrointest Surg 2001;5:21–26.PubMedCrossRef Rosemurgy AS, Bloomston M, Serafini FM, et al. Frequency with which surgeons undertake pancreaticoduodenectomy determines length of stay, hospital charges, and in-hospital mortality. J Gastrointest Surg 2001;5:21–26.PubMedCrossRef
14.
15.
go back to reference Birkmeyer JD, Dimick JB. Potential benefits of the new Leapfrog standards: Effect of process and outcomes measures. Surgery 2004;135:569–575.PubMedCrossRef Birkmeyer JD, Dimick JB. Potential benefits of the new Leapfrog standards: Effect of process and outcomes measures. Surgery 2004;135:569–575.PubMedCrossRef
16.
go back to reference U.S. Bureau of the Census. Census 2000 Summary File 1. Prepared by the U.S. Census Bureau, Washington, DC, 2001. U.S. Bureau of the Census. Census 2000 Summary File 1. Prepared by the U.S. Census Bureau, Washington, DC, 2001.
17.
go back to reference DeNavas-Walt C, Proctor BD, Lee CH. U.S. Census Bureau, Current Population Reports, P60-231. Income, Poverty, and Health Insurance Coverage in the United States: 2005, U.S. Government Printing Office, Washington, DC, 2006. DeNavas-Walt C, Proctor BD, Lee CH. U.S. Census Bureau, Current Population Reports, P60-231. Income, Poverty, and Health Insurance Coverage in the United States: 2005, U.S. Government Printing Office, Washington, DC, 2006.
20.
go back to reference Bunker JP, Luft HS, Enthoven A. Should surgery be regionalized? Surg Clin North Am 1982;62:657–668.PubMed Bunker JP, Luft HS, Enthoven A. Should surgery be regionalized? Surg Clin North Am 1982;62:657–668.PubMed
21.
go back to reference McPhee JT, Hill JS, Whalen GF, et al. Perioperative mortality for pancreatic cancer: A national perspective. Ann Surg 2007; 246:246–253PubMedCrossRef McPhee JT, Hill JS, Whalen GF, et al. Perioperative mortality for pancreatic cancer: A national perspective. Ann Surg 2007; 246:246–253PubMedCrossRef
22.
go back to reference Birkmeyer JD, Siewers AE, Marth NJ, Goodman DC. Regionalization of high-risk surgery and implications for patient travel times. JAMA 2003;290:2703–2708.PubMedCrossRef Birkmeyer JD, Siewers AE, Marth NJ, Goodman DC. Regionalization of high-risk surgery and implications for patient travel times. JAMA 2003;290:2703–2708.PubMedCrossRef
23.
go back to reference Meguid RA, Ahuja N, Chang DC. What constitutes a high-volume hospital for pancreatic resection? Abstract only. Presented at the Association for Academic Surgeons, February, 2007. Meguid RA, Ahuja N, Chang DC. What constitutes a high-volume hospital for pancreatic resection? Abstract only. Presented at the Association for Academic Surgeons, February, 2007.
24.
go back to reference Sohn TA, Yeo CJ, Lillemoe KD, et al. Resected adenocarcinoma of the pancreas—616 patients: Results, outcomes, and prognostic indicators. J Gastrointest Surg 2000;4:567–579.PubMedCrossRef Sohn TA, Yeo CJ, Lillemoe KD, et al. Resected adenocarcinoma of the pancreas—616 patients: Results, outcomes, and prognostic indicators. J Gastrointest Surg 2000;4:567–579.PubMedCrossRef
25.
go back to reference Cameron JL, Riall TS, Coleman J, Belcher KA. 1000 Consecutive pancreaticoduodenectomies by a single surgeon. Ann Surg 2006;244:10-15.PubMedCrossRef Cameron JL, Riall TS, Coleman J, Belcher KA. 1000 Consecutive pancreaticoduodenectomies by a single surgeon. Ann Surg 2006;244:10-15.PubMedCrossRef
26.
go back to reference Yeo CJ, Cameron JL, Sohn TA, Lillemoe KD, Pitt HA, Talamini MA, Hruban RH, Ord SE, Sauter PK, Coleman J, Zahurak ML, Grochow LB, Abrams RA. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: Pathology, complications, and outcomes. Ann Surg 1997;226:248–260.PubMedCrossRef Yeo CJ, Cameron JL, Sohn TA, Lillemoe KD, Pitt HA, Talamini MA, Hruban RH, Ord SE, Sauter PK, Coleman J, Zahurak ML, Grochow LB, Abrams RA. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: Pathology, complications, and outcomes. Ann Surg 1997;226:248–260.PubMedCrossRef
27.
go back to reference Yeo CJ, Lillemoe KD, Sauter PK, Coleman J, Sohn TA, Campbell KA, Choti MA, Cameron JL. Does prophylactic octreotide really decrease the rates of pancreatic fistula and other complications following pancreaticoduodenectomy? Ann Surg 2000;232:419–429.PubMedCrossRef Yeo CJ, Lillemoe KD, Sauter PK, Coleman J, Sohn TA, Campbell KA, Choti MA, Cameron JL. Does prophylactic octreotide really decrease the rates of pancreatic fistula and other complications following pancreaticoduodenectomy? Ann Surg 2000;232:419–429.PubMedCrossRef
28.
go back to reference Lillemoe KD, Cameron JL, Kim MP, et al. Does fibrin glue sealant decrease the rate of pancreatic fistula after pancreaticoduodenectomy? Results of a prospective randomized trial. J Gastrointest Surg 2004;8:766–772.PubMedCrossRef Lillemoe KD, Cameron JL, Kim MP, et al. Does fibrin glue sealant decrease the rate of pancreatic fistula after pancreaticoduodenectomy? Results of a prospective randomized trial. J Gastrointest Surg 2004;8:766–772.PubMedCrossRef
29.
go back to reference Buchler M, Friess H, Klempa I, et al. Role of octreotide in the prevention of postoperative complications following pancreatic resection. Am J Surg 1992;163:125–130.PubMedCrossRef Buchler M, Friess H, Klempa I, et al. Role of octreotide in the prevention of postoperative complications following pancreatic resection. Am J Surg 1992;163:125–130.PubMedCrossRef
30.
go back to reference Lange JR, Steinberg SM, Doherty GM, et al. A randomized, prospective trial of postoperative somatostatin analogue in patients with neuroendocrine tumors of the pancreas. Surgery 1992;112:1033–1037.PubMed Lange JR, Steinberg SM, Doherty GM, et al. A randomized, prospective trial of postoperative somatostatin analogue in patients with neuroendocrine tumors of the pancreas. Surgery 1992;112:1033–1037.PubMed
31.
go back to reference Pederzoli P, Bassi C, Falconi M, et al. Efficacy of octreotide in the prevention of complications of elective pancreatic surgery. Italian Study Group. Br J Surg 1994;81:265–269.PubMedCrossRef Pederzoli P, Bassi C, Falconi M, et al. Efficacy of octreotide in the prevention of complications of elective pancreatic surgery. Italian Study Group. Br J Surg 1994;81:265–269.PubMedCrossRef
32.
go back to reference Friess H, Beger HG, Sulkowski U, et al. Randomized controlled multicenter trial of the prevention of complications by octreotide in patients undergoing surgery for chronic pancreatitis. Br J Surg 1995;82;1270–1273.PubMedCrossRef Friess H, Beger HG, Sulkowski U, et al. Randomized controlled multicenter trial of the prevention of complications by octreotide in patients undergoing surgery for chronic pancreatitis. Br J Surg 1995;82;1270–1273.PubMedCrossRef
33.
go back to reference Montorsi M, Zago M, Mosca F, et al. Efficacy of octreotide in the prevention of pancreatic fistula after elective pancreatic resections: A prospective, controlled, randomized trial. Surgery 1995;117:26–31.PubMedCrossRef Montorsi M, Zago M, Mosca F, et al. Efficacy of octreotide in the prevention of pancreatic fistula after elective pancreatic resections: A prospective, controlled, randomized trial. Surgery 1995;117:26–31.PubMedCrossRef
34.
go back to reference Yeo CJ, Barry MK, Sauter PK, et al. Erythromycin accelerates gastric emptying following pancreaticoduodenectomy: A prospective, randomized placebo-controlled trial. Ann Surg 1993;218:229–238.PubMedCrossRef Yeo CJ, Barry MK, Sauter PK, et al. Erythromycin accelerates gastric emptying following pancreaticoduodenectomy: A prospective, randomized placebo-controlled trial. Ann Surg 1993;218:229–238.PubMedCrossRef
Metadata
Title
Trends and Disparities in Regionalization of Pancreatic Resection
Authors
Taylor S. Riall
Karl A. Eschbach
Courtney M. Townsend Jr.
William H. Nealon
Jean L. Freeman
James S. Goodwin
Publication date
01-10-2007
Publisher
Springer-Verlag
Published in
Journal of Gastrointestinal Surgery / Issue 10/2007
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-007-0245-5

Other articles of this Issue 10/2007

Journal of Gastrointestinal Surgery 10/2007 Go to the issue